PureTech Health’s Post

Wataru Momose, Ph.D. (Dr. Momo), Ph.D., Director of Business Strategy, Otsuka Pharmaceutical Co., Ltd. Co Contributed an article "Insights into Healthcare Ecosystem" "In applying this mindset to disrupt the healthcare industry ecosystem, we can unite leaders from various industries, each with unique perspectives, while aligning with the shared goal of reducing medical costs and increasing healthy life expectancy."says Wataru Momose, Ph.D. The article will also be featured in the forthcoming special print edition on Pharma Consulting 2024. Read More: https://shorturl.at/hlpV1 #medicalcosts #healthcareindustry #pharmaceuticalcompanies #drugdiscovery

Platelet Antiaggregants: Unveiling Market Trends and Innovations. Unlocking Insights in Platelet Antiaggregants Market! 🩸🔍 Our latest report delves into the trends, innovations, and strategic insights shaping the platelet antiaggregants market. Join us in understanding the pulse of this critical segment within healthcare. For more information read the full report: bit.ly/47nCVwX Some of the key players in the market are Glenmark Pharmaceuticals, Sanofi, Pfizer, Baxter International Inc. Bayer, F. Hoffmann-La Roche Ltd, Teva Pharmaceuticals, Mylan, Bausch Health Companies Inc. Johnson & Johnson, Bristol Myers Squibb, Daiichi Sankyo, Inc. Otsuka Pharmaceutical Co., Ltd. Eli Lilly and Company and many more. #marketresearchreports #news #latinamerica #marketoutlook #informesdeexpertos #ide #antiplateletdrugsmarket #antiplateletdrugs #pharmaceuticalindustry #healthcare #growth

Real world outcomes measurement is no longer a nice to have for life science industry. Post launch evidence generation requirements by HTA bodies makes it necessity to have established partnerships in place to collect real time outcomes together with healthcare providers. Join us to discuss the topic in our webinar!

The IFPMA Decision-making Framework is a very helpful tool based on the IFPMA Ethos. 👍

The importance of diversity in fostering innovation, especially in the healthcare industry, cannot be overstated. It accelerates the pace of progress, as diverse perspectives contribute to unique and effective solutions. Building a team with diverse members, including those with different and unique industrial leadership backgrounds, is therefore a crucial strategy for success. 異なる考え方や専門性を持った方をRespectし、一つのShared objectiveに向かって個々人が活躍するチームビルディングこそ、ヘルスケア業界のイノベーションに繋がると信じます。 #diversityandinclusion #leadership #healthcareinnovation #healthcareindustry

In this edition of Founders’ Q2 2024 Pharma Services M&A and Valuations Newsletter, our team shares valuable insights from the industry. The newsletter includes data points highlighting: • Market trends and insights • Market & buyer landscape map • M&A deal volume • Notable recent transactions If you or someone you know has questions about the market around the pharmaceutical services industry, please feel free to reach out to Michael White, Managing Director of Founders’ Healthcare Team & Pharma Services Sector Coverage Leader, for more information.

The Dedham Group has some of the top experts available to help with Digital Health Solutions. We can help with strategy, market shaping and other recommendations and insights. Please let me know if you would like to learn more. I am happy to facilitate a discussion with your organization. #dedhamgroup #norstella Tony Shi, MPH Manuel Jurado

Get an insight into how pharma is using VBHC! And get some pointers from my colleague Vesa Komssi!

The long-term care market is currently experiencing a trend of increasing consolidation. By building solid relationships with these key players, pharmaceutical companies can streamline their efforts and meet patients' needs more effectively. As market consolidation continues, the potential for impactful partnerships and growth in this space becomes even more promising. Stay connected with Life Sciences by PointClickCare on LinkedIn for the newest developments and expert content. #LongTermCare #Healthcare #StrategicPartnerships

🌟"Redefining Value" in the Pharma Industry: Excited to have been part of the 𝟭𝘀𝘁 𝗦𝗙𝗘𝗘 𝗦𝘂𝗺𝗺𝗶𝘁🌟 Our Partner, Angelos Benos, Pharma & Healthcare Industry Lead at PwC Greece, took the stage yesterday at the 1st SFEE Summit, during an intriguing panel on “𝗘𝗻𝗵𝗮𝗻𝗰𝗶𝗻𝗴 𝗻𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗰𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝘃𝗲𝗻𝗲𝘀𝘀 𝘁𝗵𝗿𝗼𝘂𝗴𝗵 𝗽𝗮𝗿𝘁𝗻𝗲𝗿𝘀𝗵𝗶𝗽𝘀 & 𝗶𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁𝘀 𝗶𝗻 𝗥&𝗗”💡Angelos contributed valuable insights and added depth to a discussion concerning investments of the Pharmaceutical sector in R&D and in particular Clinical Trials. Clinical trials represent a very significant Foreign Direct Investment pot that our country unfortunately has historically failed to claim its fair share and Angelos put forward certain policy initiatives that can help boost competitiveness and attract R&D investments by the Big-Pharma. #PwCGreece #SFEESummit2024 #HealthcareInnovation #GreekPharma